Pharma Journalist -

Thermo Fisher Scientific and Sanofi have announced an expansion of their strategic partnership, aimed at boosting domestic pharmaceutical manufacturing in the United States. As part of…
Read More...

Repare Therapeutics has entered into an exclusive worldwide licensing agreement with Swiss biopharmaceutical company Debiopharm International for lunresertib, a first-in-class precision…
Read More...

Boehringer Ingelheim and LEO Pharma have entered an exclusive global license and transfer agreement to commercialize and further develop SPEVIGO (spesolimab), a monoclonal antibody…
Read More...

Vertex Pharmaceuticals has announced a broad reimbursement agreement with NHS England for its cystic fibrosis (CF) treatment ALYFTREK (deutivacaftor/tezacaftor/vanzacaftor), following a…
Read More...

Otsuka Pharmaceutical Co., Ltd. has signed an asset purchase agreement with Swedish biotech firm Cantargia AB to acquire global rights to CAN10, a promising antibody drug candidate…
Read More...

Acumen Pharmaceuticals has entered into a strategic collaboration and licensing agreement with Japan-based JCR Pharmaceuticals to co-develop a next-generation Alzheimer’s disease…
Read More...

Navamedic ASA has officially completed its acquisition of DNE Pharma’s business, marking a major milestone in the company’s strategic expansion into the addiction treatment market. The…
Read More...

Secarna Pharmaceuticals and Vect-Horus have launched a strategic research collaboration to develop RNA-targeted therapeutics capable of crossing the blood-brain barrier (BBB) for…
Read More...

Transcend Therapeutics, a clinical-stage biotech focused on neuropsychiatric treatments, announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy…
Read More...

Merck Animal Health, a division of Merck & Co., Inc., announced the U.S. Food and Drug Administration (FDA) approval of BRAVECTO QUANTUM (fluralaner for extended-release injectable…
Read More...